Eric van der Putten

Eric van der Putten has an extensive background in the field of oncology drug development and clinical trials. With experience in various companies and roles such as Non-Executive Director at MIMETAS, Director at Modra Pharmaceuticals, and Partner at Aglaia Oncology Funds, Eric specializes in advancing innovative therapies for cancer treatment. Eric's previous positions include Co-founder at SMS-oncology and Vice President Oncology Europe at INC Research Netherlands BV. Eric holds a BSc in Biochemistry/Immunology and a BSc in Pathology/Histology from HBO-university Amsterdam.